Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure : A₂B Score
-
- Nakada Yasuki
- Department of Cardiovascular Medicine, Nara Medical University
-
- Kawakami Rika
- Department of Cardiovascular Medicine, Nara Medical University
-
- Matsushima Shouji
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
- Ide Tomomi
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
- Kanaoka Koshiro
- Department of Cardiovascular Medicine, Nara Medical University
-
- Ueda Tomoya
- Department of Cardiovascular Medicine, Nara Medical University
-
- Ishihara Satomi
- Department of Cardiovascular Medicine, Nara Medical University
-
- Nishida Taku
- Department of Cardiovascular Medicine, Nara Medical University
-
- Onoue Kenji
- Department of Cardiovascular Medicine, Nara Medical University
-
- Soeda Tsunenari
- Department of Cardiovascular Medicine, Nara Medical University
-
- Okayama Satoshi
- Department of Cardiovascular Medicine, Nara Medical University
-
- Watanabe Makoto
- Department of Cardiovascular Medicine, Nara Medical University
-
- Okura Hiroyuki
- Department of Cardiovascular Medicine, Nara Medical University
-
- Tsuchihashi-Makaya Miyuki
- School of Nursing, Kitasato University
-
- Tsutsui Hiroyuki
- Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
- Saito Yoshihiko
- Department of Cardiovascular Medicine, Nara Medical University
書誌事項
- タイトル別名
-
- Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure ― A<sub>2</sub>B Score ―
この論文をさがす
抄録
<p>Background: Prognosis after acute decompensated heart failure (ADHF) is poor. An appropriate risk score that would allow for improved care and treatment of ADHF patients after discharge, however, is lacking. </p><p>Methods and Results: We used 2 HF cohorts, the NARA-HF study and JCARE-CARD, as derivation and validation cohorts, respectively. The primary endpoint was all-cause death during the 2-year follow-up, excluding in-hospital death. Age, hemoglobin (Hb), and brain natriuretic peptide (BNP) at discharge were identified as independent risk factors. We determined 3 categorizations on the basis of these parameters, termed A2B score: age (<65 years, 0; 65–74 years, 1; ≥75 years, 2), anemia (Hb <10 g/dL, 2; 10–11.9 g/dL, 1; ≥12 g/dL, 0) and BNP (<200 pg/mL, 0; 200–499 pg/mL, 1; ≥500 pg/mL, 2). We divided patients into 4 groups according to A2B score (extremely low, 0; low, 1–2; medium, 3–4; high, 5–6). For the extremely low-risk group, the 2-year survival rate was 97.8%, compared with 84.5%, 66.1%, and 45.2% for the low-, medium-, and high-risk groups, respectively. Using the JCARE-CARD as a validation model, for the extremely low-risk group, the 2-year survival was 95.4%, compared with 90.2%, 75.0%, and 55.6% for the low-, medium-, and high-risk groups, respectively. </p><p>Conclusions: The user-friendly A2B score is useful for estimating survival rate in ADHF patients at discharge. </p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 83 (5), 1019-1024, 2019-04-25
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390564238088019072
-
- NII論文ID
- 130007636973
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 029661347
-
- PubMed
- 30842361
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可